Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FCRL8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,759
Award facts
- Contract value 100% obligated
- $17,759.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $17,759 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Nexplanon 68 mg implants with an ultimate completion date of December 23, 2025. This delivery order was issued without a set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The award was made under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier within the federal military medical supply chain since its registration in the System for Award Management in 2001. The company's prime vendor contract, valued at up to $499.999 billion with an ultimate completion date of December 31, 2036, positions it as one of multiple regional contractors authorized to deliver a diverse range of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring military healthcare needs globally. The delivery order for Nexplanon implants represents routine pharmaceutical procurement under this broader strategic vehicle, supporting the Department of Defense's medical operations infrastructure.
Quick answers
Who was awarded contract SPE2DR26FCRL8?
SPE2DR26FCRL8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FCRL8 worth?
The government has obligated $17,759 on SPE2DR26FCRL8.
Is contract SPE2DR26FCRL8 an order under another contract?
Yes. SPE2DR26FCRL8 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRL8 competed?
The extent of competition for SPE2DR26FCRL8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award